A Phase II/III, Multicenter, Safety, Efficacy, and Pharmacokinetic Study of Dexmedetomidine in Preterm and Term Neonates
Open Access
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 164 (2), 276-282.e3
- https://doi.org/10.1016/j.jpeds.2013.10.002
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic‐induced neuroapoptosis in the rat developing brainActa Anaesthesiologica Scandinavica, 2010
- Electrocardiographic effects of dexmedetomidine in patients with congenital heart diseaseIntensive Care Medicine, 2010
- Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicityBritish Journal of Anaesthesia, 2008
- Pro: Dexmedetomidine Should Be Used for Infants and Children Undergoing Cardiac SurgeryJournal of Cardiothoracic and Vascular Anesthesia, 2008
- Dexmedetomidine: Applications in pediatric critical care and pediatric anesthesiologyPediatric Critical Care Medicine, 2007
- Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in childrenPediatric Anesthesia, 2007
- Use of dexmedetomidine in children after cardiac and thoracic surgery*Pediatric Critical Care Medicine, 2006
- Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brainBritish Journal of Pharmacology, 2005
- The Effect of the α2-Agonist Dexmedetomidine and the N-Methyl-d-Aspartate Antagonist S(+)-Ketamine on the Expression of Apoptosis-Regulating Proteins After Incomplete Cerebral Ischemia and Reperfusion in RatsAnesthesia & Analgesia, 2003
- Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unitCritical Care Medicine, 2000